Opko Health, Inc.
4400 Biscayne Boulevard
266 articles with Opko Health, Inc.
Opko Health, Inc. Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Opko Health, Inc. Announces Early Termination of Hart-Scott-Rodino Waiting Period for Proposed Purchase of Shares by Dr. Phillip Frost